Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Alvotech (ALVOW) Cash from Operations (2021 - 2025)

Historic Cash from Operations for Alvotech (ALVOW) over the last 5 years, with Q3 2025 value amounting to -$265.9 million.

  • Alvotech's Cash from Operations fell 27120.08% to -$265.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$434.5 million, marking a year-over-year increase of 1477.8%. This contributed to the annual value of -$236.8 million for FY2024, which is 2413.38% up from last year.
  • Latest data reveals that Alvotech reported Cash from Operations of -$265.9 million as of Q3 2025, which was down 27120.08% from $143.7 million recorded in Q2 2025.
  • Over the past 5 years, Alvotech's Cash from Operations peaked at $143.7 million during Q2 2025, and registered a low of -$312.4 million during Q4 2022.
  • Its 5-year average for Cash from Operations is -$111.4 million, with a median of -$75.4 million in 2024.
  • As far as peak fluctuations go, Alvotech's Cash from Operations crashed by 34148.93% in 2022, and later skyrocketed by 38399.71% in 2025.
  • Quarter analysis of 5 years shows Alvotech's Cash from Operations stood at -$70.8 million in 2021, then tumbled by 341.49% to -$312.4 million in 2022, then rose by 0.07% to -$312.2 million in 2023, then rose by 24.13% to -$236.8 million in 2024, then decreased by 12.28% to -$265.9 million in 2025.
  • Its last three reported values are -$265.9 million in Q3 2025, $143.7 million for Q2 2025, and -$75.4 million during Q1 2025.